CORCEPT THERAPEUTICS INC Operating Income
CORCEPT THERAPEUTICS INC (CORT) reported Operating Income of $41.30 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-07-29
- CORCEPT THERAPEUTICS INC operating income (loss) for the quarter ending 2026-06-30 was $41.30M, a 54.83% increase year-over-year.
- CORCEPT THERAPEUTICS INC operating income (loss) for the quarter ending 2026-03-31 was -$49.60M, a 1552.02% decline year-over-year.
- CORCEPT THERAPEUTICS INC operating income (loss) for the quarter ending 2025-12-31 was $4.49M, a 82.24% decline year-over-year.
- CORCEPT THERAPEUTICS INC operating income (loss) for the quarter ending 2025-09-30 was $10.22M, a 78.07% decline year-over-year.
- CORCEPT THERAPEUTICS INC operating income (loss) for fiscal 2025 was $44.80M, a 67.29% decline from fiscal 2024.
- CORCEPT THERAPEUTICS INC operating income (loss) for fiscal 2024 was $136.95M, a 27.66% increase from fiscal 2023.
- CORCEPT THERAPEUTICS INC operating income (loss) for fiscal 2023 was $107.28M, a 4.75% decline from fiscal 2022.
- CORCEPT THERAPEUTICS INC operating income (loss) for fiscal 2022 was $112.63M, a 9.51% decline from fiscal 2021.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month | Operating Income (Loss) 158 month | Operating Income (Loss) 161 month | Operating Income (Loss) 164 month | Operating Income (Loss) 167 month |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $41.30M 10-Q · filed 2026-07-29 | -$8.30M 10-Q · filed 2026-07-29 | -$3.81M derived: sum of 3 quarters · filed 2026-07-29 | $6.41M derived: sum of 4 quarters · filed 2026-07-29 | ||||
| 2026-03-31 | -$49.60M 10-Q · filed 2026-04-30 | -$45.11M derived: sum of 2 quarters · filed 2026-04-30 | -$34.90M derived: sum of 3 quarters · filed 2026-04-30 | -$8.22M derived: sum of 4 quarters · filed 2026-07-29 | ||||
| 2025-12-31 | $4.49M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $14.71M derived: sum of 2 quarters · filed 2026-02-24 | $41.38M derived: sum of 3 quarters · filed 2026-07-29 | $44.80M 10-K · filed 2026-02-24 | ||||
| 2025-09-30 | $10.22M 10-Q · filed 2025-11-04 | $36.89M derived: sum of 2 quarters · filed 2026-07-29 | $40.31M 10-Q · filed 2025-11-04 | $65.57M derived: sum of 4 quarters · filed 2026-07-29 | ||||
| 2025-06-30 | $26.68M 10-Q · filed 2026-07-29 | $30.09M 10-Q · filed 2026-07-29 | $55.35M derived: sum of 3 quarters · filed 2026-07-29 | $101.95M derived: sum of 4 quarters · filed 2026-07-29 | ||||
| 2025-03-31 | $3.42M 10-Q · filed 2026-04-30 | $28.68M derived: sum of 2 quarters · filed 2026-04-30 | $75.28M derived: sum of 3 quarters · filed 2026-04-30 | $110.87M derived: sum of 4 quarters · filed 2026-04-30 | ||||
| 2024-12-31 | $25.26M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $71.86M derived: sum of 2 quarters · filed 2026-02-24 | $107.45M derived: sum of 3 quarters · filed 2026-02-24 | $136.95M 10-K · filed 2026-02-24 | ||||
| 2024-09-30 | $46.60M 10-Q · filed 2025-11-04 | $82.19M derived: sum of 2 quarters · filed 2025-11-04 | $111.69M 10-Q · filed 2025-11-04 | $143.36M derived: sum of 4 quarters · filed 2026-02-24 | ||||
| 2024-06-30 | $35.59M 10-Q · filed 2025-07-31 | $65.09M 10-Q · filed 2025-07-31 | $96.76M derived: sum of 3 quarters · filed 2026-02-24 | $127.94M derived: sum of 4 quarters · filed 2026-02-24 | ||||
| 2024-03-31 | $29.50M 10-Q · filed 2025-05-05 | $61.17M derived: sum of 2 quarters · filed 2026-02-24 | $92.35M derived: sum of 3 quarters · filed 2026-02-24 | $121.93M derived: sum of 4 quarters · filed 2026-02-24 | ||||
| 2023-12-31 | $31.67M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $62.85M derived: sum of 2 quarters · filed 2026-02-24 | $92.43M derived: sum of 3 quarters · filed 2026-02-24 | $107.28M 10-K · filed 2026-02-24 | ||||
| 2023-09-30 | $31.18M 10-Q · filed 2024-10-30 | $60.76M derived: sum of 2 quarters · filed 2024-10-30 | $75.61M 10-Q · filed 2024-10-30 | $98.11M derived: sum of 4 quarters · filed 2025-02-26 | ||||
| 2023-06-30 | $29.58M 10-Q · filed 2024-07-29 | $44.44M 10-Q · filed 2024-07-29 | $66.94M derived: sum of 3 quarters · filed 2025-02-26 | $98.87M derived: sum of 4 quarters · filed 2025-02-26 | ||||
| 2023-03-31 | $14.85M 10-Q · filed 2024-05-01 | $37.35M derived: sum of 2 quarters · filed 2025-02-26 | $69.29M derived: sum of 3 quarters · filed 2025-02-26 | $100.72M derived: sum of 4 quarters · filed 2025-02-26 | ||||
| 2022-12-31 | $22.50M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $54.43M derived: sum of 2 quarters · filed 2025-02-26 | $85.86M derived: sum of 3 quarters · filed 2025-02-26 | $112.63M 10-K · filed 2025-02-26 | ||||
| 2022-09-30 | $31.93M 10-Q · filed 2023-11-01 | $63.37M derived: sum of 2 quarters · filed 2023-11-01 | $90.14M 10-Q · filed 2023-11-01 | $126.80M derived: sum of 4 quarters · filed 2024-02-15 | ||||
| 2022-06-30 | $31.43M 10-Q · filed 2023-08-02 | $58.20M 10-Q · filed 2023-08-02 | $94.86M derived: sum of 3 quarters · filed 2024-02-15 | $131.10M derived: sum of 4 quarters · filed 2024-02-15 | ||||
| 2022-03-31 | $26.77M 10-Q · filed 2023-05-03 | $63.43M derived: sum of 2 quarters · filed 2024-02-15 | $99.67M derived: sum of 3 quarters · filed 2024-02-15 | $131.61M derived: sum of 4 quarters · filed 2024-02-15 | ||||
| 2021-12-31 | $36.66M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-15 | $72.90M derived: sum of 2 quarters · filed 2024-02-15 | $104.84M derived: sum of 3 quarters · filed 2024-02-15 | $124.48M 10-K · filed 2024-02-15 | ||||
| 2021-09-30 | $36.23M 10-Q · filed 2022-11-03 | $68.17M derived: sum of 2 quarters · filed 2022-11-03 | $87.81M 10-Q · filed 2022-11-03 | $118.32M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2021-06-30 | $31.94M 10-Q · filed 2022-08-04 | $51.58M 10-Q · filed 2022-08-04 | $82.09M derived: sum of 3 quarters · filed 2023-02-28 | $106.81M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2021-03-31 | $19.64M 10-Q · filed 2022-05-05 | $50.15M derived: sum of 2 quarters · filed 2023-02-28 | $74.87M derived: sum of 3 quarters · filed 2023-02-28 | $110.13M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2020-12-31 | $30.51M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $55.23M derived: sum of 2 quarters · filed 2023-02-28 | $90.49M derived: sum of 3 quarters · filed 2023-02-28 | $128.20M 10-K · filed 2023-02-28 | ||||
| 2020-09-30 | $24.72M 10-Q · filed 2021-11-03 | $59.98M derived: sum of 2 quarters · filed 2021-11-03 | $97.69M 10-Q · filed 2021-11-03 | $132.71M derived: sum of 4 quarters · filed 2022-02-15 | ||||
| 2020-06-30 | $35.26M 10-Q · filed 2021-07-29 | $72.97M 10-Q · filed 2021-07-29 | $107.99M derived: sum of 3 quarters · filed 2022-02-15 | $140.99M derived: sum of 4 quarters · filed 2022-02-15 | ||||
| 2020-03-31 | $37.71M 10-Q · filed 2021-05-06 | $72.73M derived: sum of 2 quarters · filed 2022-02-15 | $105.73M derived: sum of 3 quarters · filed 2022-02-15 | $130.36M derived: sum of 4 quarters · filed 2022-02-15 | ||||
| 2019-12-31 | $35.02M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-15 | $68.02M derived: sum of 2 quarters · filed 2022-02-15 | $92.65M derived: sum of 3 quarters · filed 2022-02-15 | $111.61M 10-K · filed 2022-02-15 | ||||
| 2019-09-30 | $33.00M 10-Q · filed 2020-11-03 | $57.64M derived: sum of 2 quarters · filed 2020-11-03 | $76.59M 10-Q · filed 2020-11-03 | $101.49M derived: sum of 4 quarters · filed 2021-02-23 | ||||
| 2019-06-30 | $24.63M 10-Q · filed 2020-08-04 | $43.59M 10-Q · filed 2020-08-04 | $68.49M derived: sum of 3 quarters · filed 2021-02-23 | $91.46M derived: sum of 4 quarters · filed 2021-02-23 | ||||
| 2019-03-31 | $18.96M 10-Q · filed 2020-05-04 | $43.85M derived: sum of 2 quarters · filed 2021-02-23 | $66.82M derived: sum of 3 quarters · filed 2021-02-23 | $87.46M derived: sum of 4 quarters · filed 2021-02-23 | ||||
| 2018-12-31 | $24.90M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-23 | $47.87M derived: sum of 2 quarters · filed 2021-02-23 | $68.50M derived: sum of 3 quarters · filed 2021-02-23 | $89.50M 10-K · filed 2021-02-23 | ||||
| 2018-09-30 | $22.97M 10-Q · filed 2019-11-07 | $43.60M derived: sum of 2 quarters · filed 2019-11-07 | $64.60M 10-Q · filed 2019-11-07 | $86.30M derived: sum of 4 quarters · filed 2020-02-24 | ||||
| 2018-06-30 | $20.63M 10-Q · filed 2019-08-01 | $41.63M 10-Q · filed 2019-08-01 | $63.33M derived: sum of 3 quarters · filed 2020-02-24 | $76.95M derived: sum of 4 quarters · filed 2020-02-24 | ||||
| 2018-03-31 | $21.00M 10-Q · filed 2019-05-09 | $42.69M derived: sum of 2 quarters · filed 2020-02-24 | $56.31M derived: sum of 3 quarters · filed 2020-02-24 | $69.11M derived: sum of 4 quarters · filed 2020-02-24 | ||||
| 2017-12-31 | $21.70M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24 | $35.32M derived: sum of 2 quarters · filed 2020-02-24 | $48.12M derived: sum of 3 quarters · filed 2020-02-24 | $52.85M 10-K · filed 2020-02-24 | ||||
| 2017-09-30 | $13.62M 10-Q · filed 2018-11-02 | $26.42M derived: sum of 2 quarters · filed 2018-11-02 | $31.16M 10-Q · filed 2018-11-02 | $36.16M derived: sum of 4 quarters · filed 2019-02-26 | ||||
| 2017-06-30 | $12.79M 10-Q · filed 2018-08-09 | $17.54M 10-Q · filed 2018-08-09 | $22.54M derived: sum of 3 quarters · filed 2019-02-26 | $25.61M derived: sum of 4 quarters · filed 2019-02-26 | ||||
| 2017-03-31 | $4.74M 10-Q · filed 2018-05-09 | $9.75M derived: sum of 2 quarters · filed 2019-02-26 | $12.82M derived: sum of 3 quarters · filed 2019-02-26 | $14.33M derived: sum of 4 quarters · filed 2019-02-26 | ||||
| 2016-12-31 | $5.01M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $8.08M derived: sum of 2 quarters · filed 2019-02-26 | $9.59M derived: sum of 3 quarters · filed 2019-02-26 | $10.18M 10-K · filed 2019-02-26 | ||||
| 2016-09-30 | $3.07M 10-Q · filed 2017-11-03 | $4.58M derived: sum of 2 quarters · filed 2017-11-03 | $5.17M 10-Q · filed 2017-11-03 | $6.82M derived: sum of 4 quarters · filed 2018-02-28 | ||||
| 2016-06-30 | $1.51M 10-Q · filed 2017-08-02 | $2.10M 10-Q · filed 2017-08-02 | $3.75M derived: sum of 3 quarters · filed 2018-02-28 | $3.85M derived: sum of 4 quarters · filed 2018-02-28 | ||||
| 2016-03-31 | $592.00K 10-Q · filed 2017-05-02 | $2.24M derived: sum of 2 quarters · filed 2018-02-28 | $2.35M derived: sum of 3 quarters · filed 2018-02-28 | $1.18M derived: sum of 4 quarters · filed 2018-02-28 | ||||
| 2015-12-31 | $1.65M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28 | $1.75M derived: sum of 2 quarters · filed 2018-02-28 | $587.00K derived: sum of 3 quarters · filed 2018-02-28 | -$3.44M 10-K · filed 2018-02-28 | ||||
| 2015-09-30 | $102.00K 10-Q · filed 2016-11-02 | -$1.06M derived: sum of 2 quarters · filed 2016-11-02 | -$5.09M 10-Q · filed 2016-11-02 | -$8.17M derived: sum of 4 quarters · filed 2017-03-06 | ||||
| 2015-06-30 | -$1.17M 10-Q · filed 2016-08-03 | -$5.20M 10-Q · filed 2016-08-03 | -$8.27M derived: sum of 3 quarters · filed 2017-03-06 | -$13.38M derived: sum of 4 quarters · filed 2017-03-06 | ||||
| 2015-03-31 | -$4.03M 10-Q · filed 2016-05-04 | -$7.11M derived: sum of 2 quarters · filed 2017-03-06 | -$12.21M derived: sum of 3 quarters · filed 2017-03-06 | -$18.79M derived: sum of 4 quarters · filed 2017-03-06 | ||||
| 2014-12-31 | -$3.08M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-06 | -$8.18M derived: sum of 2 quarters · filed 2017-03-06 | -$14.76M derived: sum of 3 quarters · filed 2017-03-06 | -$27.62M 10-K · filed 2017-03-06 | ||||
| 2014-09-30 | -$5.10M 10-Q · filed 2015-11-06 | -$11.68M derived: sum of 2 quarters · filed 2015-11-06 | -$24.54M 10-Q · filed 2015-11-06 | -$34.57M derived: sum of 4 quarters · filed 2016-03-10 | ||||
| 2014-06-30 | -$6.58M 10-Q · filed 2015-08-07 | -$19.44M 10-Q · filed 2015-08-07 | -$29.47M derived: sum of 3 quarters · filed 2016-03-10 | -$39.21M derived: sum of 4 quarters · filed 2016-03-10 | ||||
| 2014-03-31 | -$12.86M 10-Q · filed 2015-05-08 | -$22.89M derived: sum of 2 quarters · filed 2016-03-10 | -$32.63M derived: sum of 3 quarters · filed 2016-03-10 | -$43.41M derived: sum of 4 quarters · filed 2016-03-10 | ||||
| 2013-12-31 | -$10.03M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-10 | -$19.77M derived: sum of 2 quarters · filed 2016-03-10 | -$30.55M derived: sum of 3 quarters · filed 2016-03-10 | -$41.50M 10-K · filed 2016-03-10 | ||||
| 2013-09-30 | -$9.74M 10-Q · filed 2014-11-07 | -$20.52M derived: sum of 2 quarters · filed 2014-11-07 | -$31.47M 10-Q · filed 2014-11-07 | -$41.45M derived: sum of 4 quarters · filed 2015-03-13 | ||||
| 2013-06-30 | -$10.78M 10-Q · filed 2014-08-08 | -$21.73M 10-Q · filed 2014-08-08 | -$31.71M derived: sum of 3 quarters · filed 2015-03-13 | -$39.38M derived: sum of 4 quarters · filed 2015-03-13 | ||||
| 2013-03-31 | -$10.94M 10-Q · filed 2014-05-12 | -$20.92M derived: sum of 2 quarters · filed 2015-03-13 | -$28.59M derived: sum of 3 quarters · filed 2015-03-13 | -$36.19M derived: sum of 4 quarters · filed 2015-03-13 | ||||
| 2012-12-31 | -$9.98M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-13 | -$17.65M derived: sum of 2 quarters · filed 2015-03-13 | -$25.24M derived: sum of 3 quarters · filed 2015-03-13 | -$36.27M 10-K · filed 2015-03-13 | ||||
| 2012-09-30 | -$7.67M 10-Q · filed 2013-11-12 | -$15.26M derived: sum of 2 quarters · filed 2013-11-12 | -$26.29M 10-Q · filed 2013-11-12 | -$36.22M derived: sum of 4 quarters · filed 2014-03-14 | ||||
| 2012-06-30 | -$7.59M 10-Q · filed 2013-08-09 | -$18.62M 10-Q · filed 2013-08-09 | -$28.55M derived: sum of 3 quarters · filed 2014-03-14 | -$34.99M derived: sum of 4 quarters · filed 2014-03-14 | ||||
| 2012-03-31 | -$11.03M 10-Q · filed 2013-05-08 | -$20.96M derived: sum of 2 quarters · filed 2014-03-14 | -$27.39M derived: sum of 3 quarters · filed 2014-03-14 | -$36.26M derived: sum of 4 quarters · filed 2014-03-14 | -$224.76M 10-Q · filed 2012-05-10 | |||
| 2011-12-31 | -$9.93M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-14 | -$16.36M derived: sum of 2 quarters · filed 2014-03-14 | -$25.23M derived: sum of 3 quarters · filed 2014-03-14 | -$32.33M 10-K · filed 2014-03-14 | -$213.73M 10-K · filed 2012-03-13 | |||
| 2011-09-30 | -$6.44M 10-Q · filed 2012-11-08 | -$15.31M derived: sum of 2 quarters · filed 2012-11-08 | -$22.40M 10-Q · filed 2012-11-08 | -$30.23M derived: sum of 4 quarters · filed 2013-03-15 | -$203.80M 10-Q · filed 2011-11-08 | |||
| 2011-06-30 | -$8.87M 10-Q · filed 2012-08-09 | -$15.97M 10-Q · filed 2012-08-09 | -$23.79M derived: sum of 3 quarters · filed 2013-03-15 | -$30.90M derived: sum of 4 quarters · filed 2013-03-15 | -$197.36M 10-Q · filed 2011-08-09 | |||
| 2011-03-31 | -$7.10M 10-Q · filed 2012-05-10 | -$14.92M derived: sum of 2 quarters · filed 2013-03-15 | -$22.03M derived: sum of 3 quarters · filed 2013-03-15 | -$28.47M derived: sum of 4 quarters · filed 2013-03-15 | ||||
| 2010-12-31 | -$7.82M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-15 | -$14.93M derived: sum of 2 quarters · filed 2013-03-15 | -$21.37M derived: sum of 3 quarters · filed 2013-03-15 | -$27.44M 10-K · filed 2013-03-15 | ||||
| 2010-09-30 | -$7.11M 10-Q · filed 2011-11-08 | -$13.55M derived: sum of 2 quarters · filed 2011-11-08 | -$19.61M 10-Q · filed 2011-11-08 | |||||
| 2010-06-30 | -$6.45M 10-Q · filed 2011-08-09 | -$12.51M 10-Q · filed 2011-08-09 | ||||||
| 2009-12-31 | -$20.25M 10-K · filed 2012-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |